USA compounding pharmaceutical Market Size study, by Product Type (Oral medications, Topical medication, suppositories and others), by Therapeutic area (Pain medications, Hormone replacement therapies, Dermatological Distribution Channels and others), by Distribution Channel (Compounding pharmacies and Traditional stores) and Regional Forecasts 2020-2027

BIZ4192948
200 Pages
February 2021
Medical Devices

Download Sample Get Discount

USA compounding pharmaceutical Market is valued approximately at USD 4.51 Billion in 2019 and is anticipated to grow with a healthy growth rate of more than 5.60% over the forecast period 2020-2027. Compounding is the preparation of a personalized drug mixture to meet a patient's specific need that cannot be fulfilled by drugs that are commercially available. The compounding pharmaceuticals is gaining a significant demand from various therapeutic areas such pain medication, dermatological applications, hormone replacement therapies and others. Therefore, rising number of skin conditions is stimulating the growth of market over the forecast years. According to the American Academy of Dermatology Association, the primary skin conditions rampant among individuals in the United States include acne, psoriasis and atopic dermatitis. The compounding pharmaceuticals are precisely recommended by the doctors & dermatologists for the common skin conditions such as acne and psoriasis. Acne is the most common skin condition which affects around 50 million American population every year. Around 85% of the individuals belonging to the age group of 12 to 24 years suffers at least one minor acne. In the present scenario, acne is on the escalating mode in the United States subsequently affecting up to 15% of female population in the country. In addition, Atopic dermatitis is considered as one of the leading skin conditions prevalent among the American population. According to American Academy of Dermatology Association, 1 in 10 individuals in United States would develop atopic dermatitis during their lifetime. The prevalence of atopic dermatitis impacts around 25% of the adolescent and 2-3% of adults in United States every year. Additionally, surging rate of geriatric population is driving the growth of market over the forecast years. However, Denied approval from Food & Drug administration for compounding pharmaceuticals is restraining the growth of market.

Major market player included in this report are:

Fagron

Institutional pharmacy solutions

B.Braun Melsungen AG Company

Athenex pharma solution

Nephron pharmaceuticals corporation

Triangle compounding pharmacy

Fresenius Kabi AG

Rx3 compounding pharmacy

Clinigen group Plc

Pencol compounding pharmacy

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Product Type offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:

Oral medications

Topical medications

Suppositories

Others

By Therapeutic area:

Pain medications

Hormone replacement therapies

Dermatological applications

Others

By Distribution Channel:

Compounding pharmacies

Traditional stores

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018

Base year – 2019

Forecast period – 2020 to 2027

Target Audience of the USA compounding pharmaceutical Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. USA & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)

1.2.1. Compounding Pharmaceuticals Market, by Product Type, 2018-2027 (USD Billion)

1.2.2. Compounding Pharmaceuticals Market, by Therapeutic area, 2018-2027 (USD Billion)

1.2.3. Compounding Pharmaceuticals Market, by Distribution Channel, 2018-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. USA Compounding Pharmaceuticals Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. USA Compounding Pharmaceuticals Market Dynamics

3.1. Compounding Pharmaceuticals Market Impact Analysis (2018-2027)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. USA Compounding Pharmaceuticals Market: Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. USA Compounding Pharmaceuticals Market, by Product Type

5.1. Market Snapshot

5.2. USA Compounding Pharmaceuticals Market by Product Type, Performance - Potential Analysis

5.3. USA Compounding Pharmaceuticals Market Estimates & Forecasts by Product Type 2017-2027 (USD Billion)

5.4. Compounding Pharmaceuticals Market, Sub Segment Analysis

5.4.1. Oral medications

5.4.2. Topical medications

5.4.3. Suppositories

5.4.4. Others

Chapter 6. USA Compounding Pharmaceuticals Market, by Therapeutic area

6.1. Market Snapshot

6.2. USA Compounding Pharmaceuticals Market by Therapeutic area, Performance - Potential Analysis

6.3. USA Compounding Pharmaceuticals Market Estimates & Forecasts by Therapeutic area 2017-2027 (USD Billion)

6.4. Compounding Pharmaceuticals Market, Sub Segment Analysis

6.4.1. Pain medications

6.4.2. Hormone replacement therapies

6.4.3. Dermatological applications

6.4.4. Others

Chapter 7. USA Compounding Pharmaceuticals Market, by Distribution channel

7.1. Market Snapshot

7.2. USA Compounding Pharmaceuticals Market by Distribution channel, Performance - Potential Analysis

7.3. USA Compounding Pharmaceuticals Market Estimates & Forecasts by Distribution channel 2017-2027 (USD Billion)

7.4. Compounding Pharmaceuticals Market, Sub Segment Analysis

7.4.1. Compounding pharmacies

7.4.2. Traditional stores

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies

8.2. Company Profiles

8.2.1. Fagron

8.2.1.1. Key Information

8.2.1.2. Overview

8.2.1.3. Financial (Subject to Data Availability)

8.2.1.4. Product Type Summary

8.2.1.5. Recent Developments

8.2.2. Institutional pharmacy solutions

8.2.3. B.Braun Melsungen AG Company

8.2.4. Athenex pharma solution

8.2.5. Nephron pharmaceuticals corporation

8.2.6. Triangle compounding pharmacy

8.2.7. Fresenius Kabi AG

8.2.8. Rx3 compounding pharmacy

8.2.9. Clinigen group Plc

8.2.10. Pencol compounding pharmacy

Chapter 9. Research Process

9.1. Research Process

9.1.1. Data Mining

9.1.2. Analysis

9.1.3. Market Estimation

9.1.4. Validation

9.1.5. Publishing

9.2. Research Attributes

9.3. Research Assumption

List of Tables

TABLE 1. USA Compounding Pharmaceuticals market estimates & forecasts by Product Type 2017-2027 (USD Billion)

TABLE 2. USA Compounding Pharmaceuticals market estimates & forecasts by Therapeutic area 2017-2027 (USD Billion)

TABLE 3. USA Compounding Pharmaceuticals market estimates & forecasts by Application 2017-2027 (USD Billion)

TABLE 4. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 5. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 6. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 7. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 8. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 9. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 10. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 11. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 12. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 13. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 14. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 15. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 16. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 17. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 18. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 19. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 20. Years considered for the study

TABLE 21. Exchange rates considered

Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara